Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Dr. Reddy's Downgraded By Systematix After Semaglutide Setback; Target Price Cut — Should You Buy Or Hold?

    1 day ago

    The brokerage's cautious stance comes after Dr Reddy's disclosed that it had temporarily suspended commercial supplies of Semaglutide injections following the identification of an out-of-specification impurity during the API scale-up validation process
    Click here to Read More
    Previous Article
    Trump On Target Again? Israel Shares Intel On New Iranian Assassination Plot: Report
    Next Article
    TCS Q1 Review: Brokerages Split; Jefferies Sees 25% Downside, JPMorgan, Kotak Stay Bullish

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment